After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19 hopeful Bristol's Celgene merger sees it bounce Jounce drug pact Atlas banks $400M in its latest 'breakthrough biotech' fund Melinta wins bidding war to land deal to acquire Tetraphase Biogen posts new data for 'positive surprise' lupus med What does it mean to #BeFierce? Our new look tells the story Stanford team deploys CRISPR gene editing to fight COVID-19 FDA authorizes new Roche test for identifying high-risk COVID-19 patients FiercePharmaAsia—'Onshoring' drug manufacturing; Takeda's IBD pipeline cull; Legend's $350M IPO Chutes & Ladders—WuXi adds Celgene vet Chang to head CAR-T offerings Featured Story | Friday, June 5, 2020 Earlier this year, AbbVie tried and stumbled in a clinical trial using its HIV med Kaletra to help certain COVID-19 patients; now, it’s tapping a triumvirate of life science groups to develop a new antibody for the virus. read more |
| |
|---|
|
Top Stories Friday, June 5, 2020 After culling a $2.6 billion biobucks pact last year, Bristol Myers Squibb is making a second and final cut to its pact with I-O biotech Jounce Therapeutics. read more Friday, June 5, 2020 If there’s anything this pandemic has taught us, it's that biotech—and its investors—will not be stopped. With a $400 million raise, Atlas Venture is the latest VC shop to close a major fund since the World Health Organization officially declared COVID-19 a pandemic, joining the likes of Arch, Flagship and Deerfield. read more Friday, June 5, 2020 Melinta Therapeutics has struck a deal to buy Tetraphase Pharmaceuticals. The deal, which follows a bidding war with AcelRx Pharmaceuticals, gives Melinta another approved product and potentially complementary R&D expertise to support its bid to bounce back from bankruptcy. read more Friday, June 5, 2020 In December, Biogen delivered a “positive surprise” for its lupus candidate when all three doses of the drug outdid placebo at improving skin symptoms of the disease in a phase 2 trial. Now, the company is painting a fuller picture of the drug’s effects, including safety data, in patients with lupus limited to their skin. read more Thursday, June 4, 2020 A few years ago, one of our Fierce Life Sciences editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked. It was a glancing reference, but the comment stuck, and for good reason. We had never articulated, for ourselves or anyone else, what being Fierce actually meant. read more Friday, June 5, 2020 Stanford bioengineers teamed up with researchers at the Lawrence Berkeley National Laboratory to develop a CRISPR system that neutralizes SARS-CoV-2 by scrambling the virus's genetic code. They believe the technology could prove useful for combating several types of viruses, including influenza. read more Thursday, June 4, 2020 Roche received an emergency authorization from the FDA for a new type of coronavirus diagnostic test—not to confirm an active infection or previous exposure to the disease, but to help identify whether a person with COVID-19 has a high risk of developing severe complications. read more Friday, June 5, 2020 The pharma industry is arguing that manufacturing all drugs for the U.S. market in the U.S. is "impractical." Takeda has decided to terminate Shire's inflammatory bowel disease candidate after failing to sell it. Johnson & Johnson's CAR-T partner Legend Biotech is aiming for a $350 million IPO. And more. read more Friday, June 5, 2020 WuXi AppTec picks up Celgene vet to head CAR-T offerings; Ipsen poaches Sanofi Pasteur's Loew; Spectrum adds Dreiling to head clinical development. read more | | LabConnect is now offering global analytical and operational services to meet your COVID-19 testing requirements. We offer viral load testing by RT-qPCR and multiple COVID-19 screening assays. Connect with LabConnect today. We are here to help. |
Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Covid-19 has forever changed the paradigm of “go to the office” business operations. Learn how an effective Cloud Strategy can position your company for success in these unprecedented times. Sponsored by: Cenduit, LLC Download this case study to read about how Cenduit navigated these challenges, and successfully supports the trial sponsor to execute the umbrella trial with agility. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France BIO 2020 Now Fully Virtual: Announcing BIO Digital June 8-11, 2020 | Virtual Event Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 